Quoin Pharmaceuticals, Ltd. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Quoin Pharmaceuticals, Ltd. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2022 to Q3 2024.
  • Quoin Pharmaceuticals, Ltd. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $313K, a 16.4% increase year-over-year.
  • Quoin Pharmaceuticals, Ltd. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.23M.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $1.09M, a 42.7% increase from 2022.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $764K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.23M $313K +$44K +16.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.18M $313K +$49K +18.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.14M $306K +$45K +17.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.09M $296K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $269K +$2K +0.75% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $264K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $261K +$261K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $267K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.